Ambey Laboratories IPO Details
| IPO Size | 46.68 |
| Price Range | ₹65 - ₹68 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE |
| Minimum Quantity | 2000 |
| Investment (cut-off price) | ₹136,000 |
| Pre IPO Promotor Holding | 94.97% |
| Post IPO Promotor Holding | -- |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Ambey Laboratories IPO Timelines
03/07/2024
Start Date05/07/2024
End Date09/07/2024
Refund Initiation09/07/2024
Credit of Shares to Demat Ac10/07/2024
Listing DateAmbey Laboratories IPO Lot Size
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 2000 | ₹136,000 |
| Retail Maximum | 1 | 2000 | ₹136,000 |
| S-HNI Minimum | 2 | 4000 | ₹272,000 |
Ambey Laboratories IPO Subscription Status
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 61.90 x | 210.26 x | 195.06 x | -- | 160.18 x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹85 | ₹89.25 | ₹89.25 | ₹85 |
Ambey Laboratories IPO Company Financials
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2021 | ₹82.42 | ₹72.01 | ₹10.34 |
| FY 2022 | ₹85.11 | ₹74.26 | ₹3.57 |
| FY 2023 | ₹107.43 | ₹96.41 | ₹4.57 |
| FY 2024 (9M) | ₹100.44 | ₹87.64 | ₹6.08 |
About Company
Ambey Laboratories is a producer of agrochemical products aimed at crop protection, with a focus on producing “2, 4-D base chemicals”. The company’s manufacturing processes use technologies, such as Programmable Logic Controllers (PLC) and Supervisory Control Systems.
Currently, Ambey Laboratories’ product portfolio includes 2,4-D Acid 98% TC, 2,4-D Sodium 95% SP, 2,4-D Amine in various concentrations, 2,4-D Ethyl Hexyl Ester 96% TC, 2,4-D Ethyl Ester 96% TC, and several formulations of Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl.
These products are manufactured for their clients, including corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 1985 | Chemicals | Arpit Gupta |
Know Before Investing
Ambey Laboratories IPO Strengths
- The company’s manufacturing unit is strategically located.
- Quality Assurance Standards are strictly followed.
- It has cordial relationships with suppliers.
- Experienced promoters and management team.
Ambey Laboratories IPO Risks
- The company requires a number of approvals, licenses, registrations and permits to run the business.
- The business is seasonal in nature.
- It has reported negative cash flow in the past.
- It operates in a competitive industry.
Swot Analysis for Ambey Laboratories IPO
Strengths
Weaknesses
Opportunities
Threats
Contact Details of IXIGO
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/initial_offer/public-issues.html
Company Details
Ambey Laboratories Limited
Ground Floor, Property No.555 Tarla Mohalla,
Ghitorni, West Delhi
New Delhi, -110030
Phone: 0124-4000788
Email: [email protected]
Website: http://www.ambeylab.com/
IPO Registar Details
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/initial_offer/public-issues.html
FAQs
The key objectives of Ambey Laboratories IPO are:
- To meet out the Working Capital requirements of the Company;
- To meet out the General Corporate Purposes; and
- To meet out the Issue Expenses.